Find More Contacts for Celator Pharmaceuticals
Protected Content
Manager Operations
1 email found
View contacts for Celator Pharmaceuticals to access new leads and connect with decision-makers.
View All Contacts
  • Contact Email info@celatorpharma.com
  • Phone Number (609) 243-0123

Celator Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies to treat cancer. The company focuses on CombiPlex, a drug ratio technology platform that enables to the development of combination therapies. Its products include CPX-1 (Irinotecan HCI-Floxuridine), a treatment for colorectal cancer; and CPX-351

(Cytarabine-Daunorubicin), a treatment for acute myeloid leukemia (AML). Celator Pharmaceuticals, Inc. was formerly known as Celator Technologies, Inc. The company was founded in 2000 and is headquartered in Princeton, New Jersey.

Lists Featuring This Company

East Coast Companies With Fewer Than 1000 Employees (Top 10K)
9,903 Number of Organizations â€˘ $724.1B Total Funding Amount â€˘ 65,104 Number of Investors
Northeastern US Companies With More Than $1B in Revenue
1,434 Number of Organizations â€˘ $390.3B Total Funding Amount â€˘ 967 Number of Investors
New Jersey Biotechnology Companies
686 Number of Organizations â€˘ $25.9B Total Funding Amount â€˘ 620 Number of Investors
Health Care Companies that Exited (Top 10K)
9,989 Number of Organizations â€˘ $791.6B Total Funding Amount â€˘ 22,478 Number of Investors
Celator Pharmaceuticals was acquired by Jazz Pharmaceuticals for $1.5B on May 31, 2016. This deal was done in Cash & Stock.

Frequently Asked Questions

Where is Celator Pharmaceuticals's headquarters? Celator Pharmaceuticals is located in Princeton, New Jersey, United States.Who invested in Celator Pharmaceuticals? Celator Pharmaceuticals has 11 investors including Hercules Capital and ROTH Capital Partners.How much funding has Celator Pharmaceuticals raised to date? Celator Pharmaceuticals has raised .When was the last funding round for Celator Pharmaceuticals? Celator Pharmaceuticals closed its last funding round on Mar 23, 2016 from a Post-IPO Equity round.Who are Celator Pharmaceuticals's competitors? Alternatives and possible competitors to Celator Pharmaceuticals may include BioNTechImmunome, and NeoGenomics.